J
Jared Woo
Publications - 3
Citations - 403
Jared Woo is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 3 publications receiving 403 citations.
Papers
More filters
Journal ArticleDOI
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
Matthew E. Oster,David K. Shay,John R. Su,Julianne Gee,C. Buddy Creech,Karen R. Broder,Kathryn M. Edwards,Jonathan H. Soslow,Jeffrey M Dendy,Elizabeth P. Schlaudecker,Sean M. Lang,Elizabeth D. Barnett,Frederick L. Ruberg,M. Smith,Michael J. Campbell,Renato D. Lopes,Laurence S. Sperling,Jane A Gwira Baumblatt,Deborah Thompson,Paige Marquez,Penelope Strid,Jared Woo,River A. Pugsley,Sarah Reagan-Steiner,Frank DeStefano,Tom T. Shimabukuro +25 more
TL;DR: The risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men.
Journal ArticleDOI
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study
Ian T. Kracalik,Matthew E. Oster,Karen R. Broder,Margaret M. Cortese,Maleeka Glover,Karen Shields,C. Buddy Creech,Brittney Romanson,Shannon A. Novosad,Jonathan H. Soslow,Emmanuel B. Walter,Paige Marquez,Jeffrey M Dendy,Jared Woo,Amy L. Valderrama,Alejandra Ramirez-Cardenas,Agape Assefa,Michael J. Campbell,John R. Su,Shelley S. Magill,David K. Shay,Tom T. Shimabukuro,Sridhar V. Basavaraju,P. Campbell,Chidera Anugwom,Colenda Arvelo Jefferson,Kimberly Badger,Nastocia Bafford,Chandra Barnes,Stephanie Reeve Boles,Emory D. Collins,Mitesh Desai,T. Dulski,Barbara Dyleski,Kathryn M. Edwards,Melanie C. Feyereisen,Stephanie Gonsahn,Tchernavia Gregory,Jyothi Gunta,Kara Jacobs Slifka,Charlotte D. Kaboré,Bryan K. Kapella,Susan V. Karol,Kalah Kennebrew,Nancy Kluisza,Sean M. Lang,Labretta Lanier Gholston,Marc T. Law,Jennifer A. Lehman,Jacek M. Mazurek,Henraya F. McGruder,Kiara McNamara,Martha L Moore,Pedro L. Moro,John F. Moroney,Oidda I. Museru,Cassandra Nale,Andrea Neiman,Kim Newsome,Erika Odom,Brooke G. Pantazides,Suchita A. Patel,Agam K Rao,Laura Reynolds,Sonya Robinson,Frederick L. Ruberg,Tammy L. Schaeffer,Dipesh Solanky,Laurence S. Sperling,Toscha R Stanley,Regina D. Sullivan,Allan W. Taylor,Kimberly Thomas,Shayle Thompson,Jigsa A. Tola,Cuc H. Tran,Steven T. Wiersma,K Works +77 more
TL;DR: After at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination, most individuals in this cohort were considered recovered by health-care providers, and quality of life measures were comparable to those in pre-pandemic and early pandemic populations of a similar age.
Journal ArticleDOI
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States
Winston E. Abara,Julianne Gee,Paige Marquez,Jared Woo,T. R. Myers,Allison DeSantis,Jane Baumblatt,Emily Jane Woo,Deborah Thompson,Narayan Nair,John R. Su,Tom T. Shimabukuro,David K. Shay +12 more
TL;DR: In this article , the authors investigated the association of Ad26.COV2.S, BNT162b2, and mRNA-1273 COVID-19 vaccination with rates of Guillain-Barré syndrome among US adults.